bluebird bio Files 8-K: Other Events & Financials
| Field | Detail |
|---|---|
| Company | Bluebird Bio, Inc. |
| Form Type | 8-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, financials
TL;DR
Bluebird bio filed an 8-K. Likely routine updates on financials and events.
AI Summary
On March 28, 2025, bluebird bio, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and operational events. No specific new financial figures or significant events were detailed in the provided excerpt.
Why It Matters
This filing signals that bluebird bio is providing updates to the SEC, which could contain material information for investors regarding the company's operations or financial health.
Risk Assessment
Risk Level: low — The provided excerpt is a standard SEC filing notification and does not contain specific material events or financial data that would indicate a change in risk.
Key Numbers
- 001-35966 — SEC File Number (Identifies the company's filing with the SEC.)
- 13-3680878 — IRS Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- bluebird bio, Inc. (company) — Registrant
- Genetix Pharmaceuticals Inc (company) — Former company name
- 455 Grand Union Boulevard (location) — Principal executive offices address
- Somerville, Massachusetts (location) — City and State of principal executive offices
FAQ
What specific 'Other Events' are being reported by bluebird bio, Inc. on March 28, 2025?
The provided excerpt does not detail the specific 'Other Events' being reported; it only indicates that this item is part of the 8-K filing.
What is the significance of filing 'Financial Statements and Exhibits' in this 8-K?
This indicates that bluebird bio is providing updated financial information or exhibits to the SEC, which could include financial statements or related documents.
When was bluebird bio, Inc. incorporated or organized?
The company was incorporated or organized in Delaware, as stated in the filing.
What was bluebird bio, Inc.'s former company name?
The former company name was Genetix Pharmaceuticals Inc, with a date of name change on June 16, 2004.
What is the principal executive office address for bluebird bio, Inc.?
The principal executive office is located at 455 Grand Union Boulevard, Somerville, Massachusetts 02145.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 28, 2025 regarding bluebird bio, Inc..